A case of oral lichenoid reaction during nivolumab therapy-Reference-Cited by-同舟云学术

A case of oral lichenoid reaction during nivolumab therapy

Published:2020-11 Issue:6 Volume:32 Page:521-524
ISSN:2212-5558
Container-title:Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
language:en
Short-container-title:Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology

Author:

Yamanaka Shigeki,Nakao Kazumasa,Ninomiya Aya,Watanabe Takuma^ORCID,Inoue Yu,Kashiwagi Marina,Fukuhara Shizuko,Asai Keita,Yamaguchi Akihiko,Kataoka Tatsuki,Bessho Kazuhisa

Publisher

Elsevier BV

Subject

Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine,Surgery

Reference11 articles.

1. Drug-induced oral lichenoid reaction during nivolumab therapy;Enomoto;Int J Oral Maxillofac Surg,2019

2. Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings;Sibaud;J Eur Acad Dermatol Venereol,2017

4. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes;Freeman-Keller;Clin Cancer Res,2016

5. Nivolumab-induced lichen planus pemphigoides;Strickley;Cutis,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral lichenoid lesions as an immune‐related adverse event: A rare case report and literature review;Oral Science International;2024-09-07

2. Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance;Cutaneous and Ocular Toxicology;2022-01-02